Skip to main content

Table 6 Association between patient demographic characteristics and ESBL-E. coli bacteriuria episode among all E. coli bacteriuria episodes or drug-resistant E. coli bacteriuria episodes, multivariate analyses

From: Trends in prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolated from patients with community- and healthcare-associated bacteriuria: results from 2014 to 2020 in an urban safety-net healthcare system

 

RR (95% CI)

 

Community-onset

Healthcare-onset/associated

 

ESBL-E. coli among all E. coli episodes

ESBL-E. coli among AMR E. coli episodes

ESBL-E. coli among all E. coli episodes

ESBL-E. coli among AMR E. coli episodes

Age category (years)

    

0–17 (reference)

    

18–34

0.84 (0.50, 1.41)

0.83 (0.51, 1.35)

1.87 (3.03E−19, 1.15E+19)

1.37 (3.78E−16, 5.01E+15)

35–64

1.41 (0.88, 2.26)

1.29 (0.81, 2.05)

3.92 (8.69E−23, 1.76E+23)

2.90 (4.64E−18, 1.81E+15)

65 + 

1.88 (1.17, 3.05)

1.60 (0.98, 2.61)

2.74 (1.99E−22, 3.78E+22)

2.26 (4.17E−18, 1.23E+18)

Gender

    

Female (reference)

    

Male

2.12 (1.65, 2.73)

1.90 (1.50, 2.41)

1.53 (1.03, 2.26)

1.36 (0.96, 1.92)

Race/ethnicity

    

Asian

0.96 (0.62, 1.48)

0.94 (0.62, 1.44)

0.78 (0.45, 1.35)

0.88 (0.51, 1.52)

Black

0.83 (0.52, 1.32)

0.83 (0.54, 1.26)

0.85 (0.50, 1.44)

0.79 (0.50, 1.26)

Latinx

1.52 (0.99, 2.33)

1.39 (0.98, 1.98)

1.35 (0.72, 2.54)

1.20 (0.73, 1.97)

Other

1.41 (0.84, 2.35)

1.28 (0.82, 1.99)

0.93 (0.50, 1.73)

0.94 (0.53, 1.66)

White (reference)

    

Preferred language

    

Chinese dialect

1.36 (0.86, 2.15)

1.39 (0.88, 2.21)

1.15 (0.53, 2.47)

1.12 (0.55, 2.25)

English (reference)

    

Other

1.18 (0.76, 1.83)

1.25 (0.80, 1.94)

1.41 (0.77, 2.56)

1.33 (0.74, 2.39)

Spanish

0.97 (0.73, 1.30)

0.88 (0.67, 1.17)

0.90 (0.50, 1.60)

0.85 (0.53, 1.37)

  1. Note: Multivariate logistic regressions including all variables presented above. Cluster bootstrap confidence intervals presented. Data from a public healthcare system; RR: risk ratio, ESBL: extended-spectrum beta-lactamase, AMR: antimicrobial resistant